✦ LIBER ✦

Phase II trial with weekly cisplatin (CDDP) and continously oral etoposide (VP-16) in advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Lopez, R.; Fernandez, R.; Virizuela, J.A.; Cueva, J.; Garcia, E.; Sanz, A.; Valerdi, J.J.; Gracia, J.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial with oral etoposide (VP

✍ Gracia, J.M.; Fernández, R.; Cueva, J.; Virizuela, J.A.; García, E.; Sanz, A.; L 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Navelblne (NVB), oral etoposide (VP16),

✍ López, J.O.; Federico, C. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 267 KB

A multicentre phase II trial of cisplati

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Oral etoposide preceding cisplatin in ad

✍ Focan, C.; Vandermoten, G.; Boossy, J.; Schallier, D. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 571 KB

102 Navelbine (NVB), oral etoposide (VP1

✍ López, J.O.; Federico, C. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 162 KB

148 A phase II trial of oral UFT plus ci

✍ Saito, J.; Nakai, Y.; Koinumaru, S. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 157 KB